Ranitidine bismuth citrate: A review
Recognition of the relationship between Helicobacter pylori infection and the development of gastroduodenal disease has increased greatly in recent years. To avoid complications of H pylori infection, such as the development of recurrent duodenal and gastric ulcers, effective therapies are required...
Saved in:
Main Authors: | N Chiba, RH Hunt, ABR Thomson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2001-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2001/925106 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Randomized Trial Comparing Seven-Day Ranitidine Bismuth Citrate and Clarithromycin Dual Therapy to Seven-Day Omeprazole, Clarithromycin and Amoxicillin Triple Therapy for the Eradication of Helicobacter pylori
by: Sander Veldhuyzen van Zanten, et al.
Published: (2003-01-01) -
Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
by: K Lauritsen, et al.
Published: (1999-01-01) -
Canadian Helicobacter pylori Consensus Conference Update: Infections in Adults
by: RH Hunt, et al.
Published: (1999-01-01) -
Alginate microspheres obtained by the spray drying technique as mucoadhesive carriers of ranitidine
by: Szekalska Marta, et al.
Published: (2015-03-01) -
Prevention of Relapse in Reflux Esophagitis: A Placebo Controlled Study of Ranitidine 150 mg BID and 300 mg BID
by: John H Hegarty, et al.
Published: (1997-01-01)